Skin-Care Claims Before And After FDA Warning Letters

A side-by-side comparison of product claims cited in FDA warning letters and updated claims being used by recipients following their compliance work with the agency. The analysis could provide cues as to promotional language that can be employed without provoking a regulatory response.

More from Regulation

More from Policy & Regulation